Search Results - "Magaret, A.S"

Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract by Posavad, C M, Zhao, L, Dong, L, Jin, L, Stevens, C E, Magaret, A S, Johnston, C, Wald, A, Zhu, J, Corey, L, Koelle, D M

“…Local mucosal cellular immunity is critical in providing protection from HSV-2. To characterize and quantify HSV-2-reactive mucosal T cells, lymphocytes were…”
Get full text

Building global development strategies for cf therapeutics during a transitional cftr modulator era by Mayer-Hamblett, N., van Koningsbruggen-Rietschel, S., Nichols, D.P., VanDevanter, D.R., Davies, J.C., Lee, T., Durmowicz, A.G., Ratjen, F., Konstan, M.W., Pearson, K., Bell, S.C., Clancy, J.P., Taylor-Cousar, J.L., De Boeck, K., Donaldson, S.H., Downey, D.G., Flume, P.A., Drevinek, P., Goss, C.H., Fajac, I., Magaret, A.S., Quon, B.S., Singleton, S.M., VanDalfsen, J.M., Retsch-Bogart, G.Z.

“…•Advancement of the CF therapeutics pipeline remains an important goal.•Availability of CFTR modulators impacts future CF clinical development.•Global…”
Get full text